Xenon Pharmaceuticals Inc...

NASDAQ: XENE · Real-Time Price · USD
37.35
-0.47 (-1.24%)
At close: Aug 19, 2025, 3:59 PM
37.36
0.03%
After-hours: Aug 19, 2025, 04:25 PM EDT

Xenon Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-234.33M -182.39M -125.37M -78.88M
Depreciation & Amortization
2.56M 3.54M 1.62M 906K
Stock-Based Compensation
50.72M 32.37M 20.38M 10.02M
Other Working Capital
6.33M 1.57M -10.49M -2.19M
Other Non-Cash Items
11.09M -4.19M 5.66M 1.05M
Deferred Income Tax
-8.86M -292K -44K 58K
Change in Working Capital
5.71M 5.63M -676K -2.65M
Operating Cash Flow
-181.39M -145.33M -98.43M -69.5M
Capital Expenditures
-3.08M -5.62M -2.89M -2.05M
Cash Acquisitions
n/a n/a 296M -144.75M
Purchase of Investments
n/a -793.91M -551.14M -389.47M
Sales Maturities Of Investments
n/a 682.35M 258.03M 144.75M
Other Investing Acitivies
165M n/a -296M 144.75M
Investing Cash Flow
165M -117.17M -296M -246.77M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 35K 705K 260K
Financial Cash Flow
12.13M 353.52M 278.47M 447.54M
Net Cash Flow
-5.93M 91.4M -118.45M 130.68M
Free Cash Flow
-184.46M -150.94M -101.32M -71.55M